Total number of publications: 158
2026
-
Imunoterapie checkpoint inhibitory indikovaná podle doporučení molekulárního tumor boardu na základě hodnoty nádorové mutační nálože (TMB): Reálné výsledky z české národní platformy precizní onkologie GENESIS
Year: 2026, type: Conference abstract
-
Molekulární profily a genomicky řízená léčba GI nádorů u mladých dospělých vs. pacientů s průměrným věkem nástupu nemoci: data české národní sítě precizní medicíny GENESIS
Year: 2026, type: Appeared in Conference without Proceedings
2025
-
157P Real-world outcomes of checkpoint inhibitors guided by molecular testing and tumor mutation burden (TMB): Results from Czech national precision medicine network study GENESIS
Year: 2025, type: Conference abstract
-
Implementing performance-based risk-sharing agreements in non-small cell lung cancer immunotherapy: a real-world data case study
HEALTH ECONOMICS REVIEW, year: 2025, volume: 15, edition: 1, DOI
-
Intermittent enteral nutrition shortens the time to achieve nutritional goals in critically ill patients
Scientific Reports, year: 2025, volume: 15, edition: 1, DOI
-
Molecular profiles and genomic therapy in young vs. average-onset gastrointestinal (GI) cancers: A Czech national precision medicine network study, GENESIS
Year: 2025, type: Conference abstract
-
Real-World Data From a Molecular Tumor Board-Assisted Cancer Care From a Single Center in The Czech Republic: Is Precision Oncology an Accessible Option, or a Privilege for a Minority of Patients?
Cancer Medicine, year: 2025, volume: 14, edition: 15, DOI
-
Skeletal Muscle Loss During Treatment With Abiraterone in Patients With Metastatic Prostate Cancer
PROSTATE CANCER, year: 2025, volume: 2025, edition: 1, DOI
2024
-
Dexamethasone doses in patients with COVID-19 and hypoxia: A systematic review and meta-analysis
Acta Anaesthesiologica Scandinavica, year: 2024, volume: 68, edition: 2, DOI
-
Effects of two different dexamethasone dosing regimens on ventilator-free days and long-term mortality in COVID-19 patients with moderate-to-severe ARDS: the REMED randomized clinical trial
European Journal of Medical Research, year: 2024, volume: 29, edition: 1, DOI